Table II.
Periprocedural and 30-day results
| Parameter | All patients (n = 214) | Symptomatic patients (n = 121) (57%) | Asymptomatic patients (n = 93) (43%) |
|---|---|---|---|
| Internal carotid artery stenosis, mean ± SD (%) | 88 ±9 | 88 ±10 | 88 ±7 |
| Contralateral total occlusion, n (%) | 8 (4) | 7 (6) | 1 (1) |
| Efficacy, n (%) | 206 (96) | 117 (97) | 89 (96) |
| Any death, n (%) | 0 | 0 | 0 |
| Cardiovascular death, n (%) | 0 | 0 | 0 |
| Stroke, n (%) | 5 (2) | 5 (4)* | 0 |
| TIA, n (%) | 10 (5) | 7 (6) | 3 (3) |
| Intracranial haemorrhage, n (%) | 0 | 0 | 0 |
| MI, n (%) | 1 (0.5) | 1 (1) | 0 |
| CIN, n (%) | 7 (3) | 4 (3) | 3 (3) |
| Bradycardia requiring PM implantation, n (%) | 1 (0.5) | 1 (1) | 0 |
| Hypotonia requiring dopamine infusion, n (%) | 3 (1) | 2 (2) | 1 (1) |
| Access site hematoma requiring intervention, n (%) | 2 (1) | 0 | 2 (2) |
Data are presented as numbers and percentages for categorical variables. Quantitative values with normal distribution are shown as mean ± standard deviation.
*
p < 0.05
TIA – transient ischaemic attack, MI – myocardial infarction, CIN – contrast induced nephropathy, PM – pacemaker